Advances in MRI assessment of gliomas and response to anti-VEGF therapy (Q33793253)

29 July 2017

5 references

3 April 2019

20 November 2019

20 August 2020

9 September 2020

5 November 2020

Advances in MRI assessment of gliomas and response to anti-VEGF therapy (English)

1 reference

vascular endothelial growth factor A

29 July 2017

5 references

3 April 2019

20 November 2019

20 August 2020

9 September 2020

5 November 2020

1 reference

20 November 2019

1 reference

magnetic resonance imaging

20 August 2020

1 reference

9 September 2020

angiogenesis inhibitor

1 reference

5 November 2020

Jonathan R Young

2

0 references

Benjamin M Ellingson

object named as

Benjamin M Ellingson

series ordinal

3

0 references

author name string

Whitney B Pope

series ordinal

1

1 reference

29 July 2017

publication date

1 June 2011

6 references

Current Neurology and Neuroscience Reports

29 July 2017

3 April 2019

20 November 2019

20 August 2020

9 September 2020

5 November 2020

6 references

29 July 2017

3 April 2019

20 November 2019

20 August 2020

9 September 2020

5 November 2020

11

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

336-344

1 reference

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Pseudoprogression and pseudoresponse in the treatment of gliomas

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Novel anti-angiogenic therapies for malignant gliomas

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Glioblastoma multiforme: radiologic-pathologic correlation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

4 July 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Effect of bevacizumab on radiation necrosis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Prognostic value of choline and creatine in WHO grade II gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-011-0179-X

Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075404

Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced pe

30 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234719

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234719

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11910-011-0179-X

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference